News for Generex Biotechnology Corporation (GNBT)

/PRNewswire/ -- The "Protein Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to...

The recombinant cancer vaccines segment accounts for the largest market share. North America is expected to possess 40% market share for the Cancer...

/PRNewswire/ -- Cancer Vaccines Market Research Report by Technology, Treatment Method, Application, Region - Global Forecast to 2027 - Cumulative Impact of...

Read Generex Biotechnology (OTCMKTS:GNBT) Stock Price Passes Above 200 Day Moving Average of $0.00 at ETF Daily News

Read Contrasting Enveric Biosciences (NASDAQ:ENVB) and Generex Biotechnology (OTCMKTS:GNBT) at ETF Daily News

/PRNewswire/ -- Cancer Vaccines Market was worth of USD 4.93 Billion in 2020 and it is expected to reach USD 12.64 Billion by the end of 2027 with a CAGR of...

/PRNewswire/ -- Polaris Market Research recently published a research report on "Buccal Drug Delivery System Market Share, Size, Trends, Industry Analysis...

MIRAMAR, Fla., July 26, 2021 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) subsidiary Olaregen Therapeutix announced in…

Other Events. On July 22, 2021, Generex Biotechnology Corporation on behalf of itself and its subsidiary NuGenerex Immuno-Oncology, Inc. entered into a Quality Agreement with... | July 23, 2021

MIRAMAR, Fla., June 22, 2021 (GLOBE NEWSWIRE) — NuGenerex Immuno-Oncology (NGIO – www.nugenerexio.com), a subsidiary of Generex Biotechnology Corporation…

Ii-Key Immunotherapeutic Vaccine TechnologyIi-Key-SARS-CoV-2 Vaccine Market Potential & International ContractsMarket Potential for AE37 Immunotherapeutic Vaccine for breast, prostate, and... | June 22, 2021

Ii-Key Immunotherapeutic Vaccine TechnologyIi-Key-SARS-CoV-2 Vaccine Market Potential & International ContractsMarket Potential for AE37 (Ii-Key-HER2)...

MIRAMAR, Fla., May 10, 2021 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative…

Update on Ii-Key-SARS-CoV-2 vaccine program Appointment of Dr. Craig Eagle to be Chairman of the Board of NuGenerex Immuno-Oncology Inc. pending board

MIRAMAR, Fla., March 31, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB: GNBT) ("Generex or the "Company"), an innovative and integrated